Transduction of a cellular oncogene: The genesis of Rous sarcoma virus by Swanstrom, R. et al.
Proc. Natl Acad. Sci. USA
Vol. 80, pp. 2519-2523, May 1983
Biochemistry
Transduction of a cellular oncogene: The genesis of Rous
sarcoma virus
(recombination/splicing/genetic transposition)
RONALD SWANSTROM*, RICHARD C. PARKER, HAROLD E. VARMUS, AND J. MICHAEL BISHOPt
Department of Microbiology and Immunology, University of California, School of Medicine, San Francisco, California 94143
Contributed byJ. Michael Bishop, January 28, 1983
ABSTRACT The oncogene of Rous sarcoma virus (v-src) arose
by transduction of a cellular gene (c-src). In an effort to explore
the mechanism of transduction, we have identified the splice ac-
ceptor site used in the genesis of mRNA for v-arc, shown that an
equivalent site is used in the splicing of mRNA for c-src, and de-
termined the nucleotide sequence from the boundaries of ho-
mology between v-arc and c-src. Our data indicate that (i) only a
portion of c-src is represented within v-src, (ii) the leftward re-
combination between the genome of the transducing virus and c-
src occurred in an intron of the cellular gene, (iii) v-arc is in part
a spliced version of the corresponding portion of c-src, and (iv)
nucleotide sequences represented once in the genome of the trans-
ducing virus become duplicated to flank v-src. These findings in-
dicate that the first step in transduction is probably recombination
between DNA forms of the transducing viral genome and c-src
and otherwise support the prevailing model for transduction by
retroviruses. The carboxyl termini of the proteins encoded by v-
arc and c-src differ appreciably. An unidentified domain of 127
or 128 nucleotides is located at different positions in the genomes
of two strains of RSV and gives evidence of being a foreign ele-
ment that entered the viral genomes by genetic transposition in-
dependent of the transduction of arc.
The oncogenes of retroviruses arose by transduction of cellular
genes (1). The mechanism of transduction has yet to be elu-
cidated but previous comparisons of retroviral oncogenes and
their cellular progenitors have engendered several hypothetical
models. Chief among these is a scheme in which transduction
is mediated by two separate steps of recombination-the first
between the DNA forms of a retroviral genome and a cellular
gene, the second between a chimeric RNA transcribed from the
product of the first recombination and the RNA genome of a
retrovirus (see Discussion).
The cellular origins of oncogenes were originally recognized
from studies of the oncogene (v-src) of Rous sarcoma virus (RSV)
and its cellular progenitor (c-src) (2). In an effort to test the models
for transduction by retroviruses, we have identified the splice
acceptor site used in the genesis ofmRNA for v-src, shown that
an equivalent site is used in the splicing ofmRNA for c-src, and
determined the nucleotide sequence from the boundaries of
homology between v-src and c-src. Our results provide evi-
dence that the first step in transduction is indeed recombina-
tion between viral and cellular DNAs and otherwise support
the prevailing model for transduction. In addition, we have found
that proteins encoded by v-src and c-src differ appreciably at
their carboxyl termini, and we have identified a domain of 127
or 128 nucleotides (denoted X) that is located at different po-
sitions in the genomes of the Schmidt-Ruppin subgroup A (SR-
A) and Prague subgroup C (Pr-C) strains of RSV.
MATERIALS AND METHODS
We have previously described the preparation of molecular clones
of v-src (3) and c-src (4), the identification of splice junctions
(5) by the use of nuclease SI (6, 7), the isolation of polyadenyl-
ylated cellular RNA (8), and the determination of the nucleo-
tide sequence (9) by the procedure of Maxam and Gilbert (10).
A corrected version (11) of our previous sequence for v-src and
its environs in SR-A RSV (12) has been used for present pur-
poses. The sequence of the Pr-C RSV genome was provided in
advance of publication by D. Schwartz, R. Tizzard, and W. Gil-
bert (13).
RESULTS
The Boundaries of Homology Between v-src and c-src. Pre-
vious studies with heteroduplexes located the approximate
boundaries of homology between v-src and c-src (4, 14, 15). We
used molecular hybridization to identify and isolate DNA en-
compassing these boundaries within molecular clones of c-src
(Fig. 1A) and then determined the nucleotide sequence of the
isolated DNAs.
Sequences from c-src and the genome of SR-A RSV are aligned
across the leftward boundary of homology in Fig. 1B. The two
sequences diverge at a point 92 nucleotides upstream from the
initiation codon of v-src (11, 12), as reported (13). The diver-
gence defines the point of recombination between transducing
virus and c-src and resides in an intron of c-src (see below). To
the right of the point of recombination, the nucleotide se-
quences of c-src and the genome of SR-A RSV are homologous
to a point 10 nucleotides upstream from the initiation codon of
v-src, where the sequences again diverge (Fig. 1B). The di-
vergence locates the rightward boundary of an exon in c-src
(Fig. 1A), manifested by the presence in c-src of a consensus
sequence for a splice donor site (Fig. 1B).
In a search for homology between transducing virus and c-
src, we aligned sequences from c-src, SR-A RSV, Pr-C RSV,
and RAV-0-an endogenous retrovirus of chickens that is closely
related to replicative elements in RSV but carries no oncogene
(Fig. 1C). Potential sites of recombination with c-src were ap-
parent from the alignments. The sites for SR-A and Pr-C were
at different but not widely separated positions in the genome
of RAV-0. There is no homology between c-src and the poten-
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FIG. 1. The leftward boundary of homology between c-src and v-src.
(A) Location of the boundary. The topographies of v-src and c-src are
presented schematically. The open boxes represent regions of homology
between v-src and c-src. The homology with v-src in c-src is interrupted
by introns identified previously (4, 14,15) and perhaps others. The heavy
diagonal lines denote the regions of c-src that contain the leftward and
rightward boundaries of homology with v-src. Additional exons may be
present in c-src outside of the regions of homology with v-src, as de-
noted by the incomplete boxes. (B) Identifying the leftward boundary.
The nucleotide sequences of SR-A RSV and c-src have been aligned to
identify points of divergence (denoted by offsetting of the sequences).
The numbering scheme designates the first nucleotide 5' of the initi-
ation codon for v-src (underlined) as -1. The underlining of the c-src
sequence locates a consensus sequence for a splice donor site (16). (C)
Searching for homology between transducing virus and c-src. The nu-
cleotide sequences of the genomes of RAV-0 (17), SR-A RSV (11, 12),
Pr-C RSV (13), and c-src have been aligned across the leftward bound-
ary of homology between v-src and c-src. The boundary is represented
by the transition from homology with RAV-0 to homology with c-src. A
dinucleotide (T-G) shared by c-src, v-src in SR-A RSV, and RAV-0 at the
putative site of recombination forSR-ARSV is underlined. The vertical
bar above the RAV-0 sequence denotes the leftward boundary of U3,
a domain at the 3' terminus of the viral RNA genome that composes
part of the large terminal repeat in the proviruses of retroviruses (18).
tial recombinatory site for Pr-C RSV in the genome of RAV-0.
By contrast, c-src and RAV-O share a dinucleotide (T-G) at the
putative site of recombination for SR-A RSV (Fig. 1C).
When we examined the rightward extreme of homology be-
tween v-src and c-src, ambiguities emerged (Fig. 2). The nu-
cleotide sequences of v-src and c-sr-c diverge five residues up-
stream from the previously defined termination codon for v-src
(11, 12). A potential open reading frame of c-src continues for
another 12 codons before terminating in TGA. As a conse-
quence, amino acids at the carboxyl terminus of v-src are not
found in c-src and c-src must therefore conclude with amino
acids not found in v-src. These findings pose several problems.
First, we cannot account for the origin of the carboxyl terminus
of v-src in either SR-A or Pr-C RSV. Second, we cannot be cer-
tain that we have correctly described the carboxyl terminus of
c-src. For example, our identification of the termination codon
for c-src would be incorrect if a splice donor site lies to the left
of that codon, or if the splice acceptor site proposed for c-src
in Fig. 2 is not used. Third, we cannot as yet identify the right-
ward point of recombination with c-src. The nucleotide se-
quence extending for =95 residues beyond the termination co-
don in v-src can be accounted for only be combining domains
of homology with the genomes of RAV-0 and the PRC-II avian
sarcoma virus (unpublished data), and it is therefore unlikely
that any single retrovirus for which the nucleotide sequence is
currently available could be implicated in the rightward re-
combination with c-src. If our interpretation of the available
sequences is correct, however, the recombination occurred in
the vicinity of the present termination codon for v-src-very
possibly, to its 5' side.
A Splice Acceptor Site Shared Between v-src and c-src. The
genesis of mRNA for v-src uses a splice donor site located 389
nucleotides from the 5' end of the viral genome (5, 9) and a
previously unidentified splice acceptor site upstream of the ini-
tiation codon for v-src (19-21). We mapped the position of the
splice acceptor site by using an end-labeled restriction frag-
ment of DNA that spans the splice acceptor site in mRNA for
v-src (Fig. 3A). Hybridization of the fragment to genome RNA
of SR-A RSV rendered the DNA resistant to hydrolysis by nu-
clease S1 (Fig. 3B, lane 5). By contrast, hybridization of the re-
striction fragment to RNA from cells infected with SR-A RSV
produced both DNA that was fully resistant to nuclease S1 and
DNA that was reduced to a length of -100 nucleotides by hy-
drolysis with the nuclease (lane 6). When RNA from uninfected
chicken cells was used in the hybridizations, the smaller (and
only the smaller) product of hydrolysis was obtained (lane 7).
These results were achieved by using RNA from uninfected cells
in amounts at least 100 times those used for RNA from infected
cells. We therefore attribute the small DNA fragment to hy-
bridization with v-src mRNA in the case of infected cells, whereas
the fragment of necessity arises from c-src mRNA in the case
of uninfected cells. We conclude that the size of the smaller
fragment defines the approximate location of the splice accep-
tor site upstream of v-src and that an equivalent site is used in





FIG. 2. The rightward boundary of homology between v-src and c-src. Nucleotide sequences from the rightward-most region of homology that
we could identify have been aligned. Divergence is indicated by the off-set sequences. Underlining denotes the previously identified termination
codon for v-src (TAG), a candidate termination codon for c-src (TGA), and a consensus sequence for a splice acceptor site (16) in c-src. The predicted
amino acid sequences are shown above and below the nucleotide sequences.




































FIG. 3. Mapping a splice acceptor site shared by v-src and c-src. (A)
The strategy. A fragment of DNA derived from the appropriate domain
of the RSV genome and labeled on one end only (star) was used to map
the splice acceptor site. Details of our procedures have been described
(5) and follow the original design of Weaver and Weissman (7). ATG,
The initiation codon for v-src. (B) Analysis of DNAs protected from hy-
drolysis by nuclease S1. The end-labeled DNA (A) was hybridized with
viral and cellular RNAs, hydrolyzed with nuclease S1, and analyzed by
electrophoresis in a 4% polyacrylamide/8 M urea gel (10). An auto-
radiograph of the gel after completion of electrophoresis is shown. Lanes:
1, marker DNA, -100 nucleotides long, obtained by cleaving the end-
labeled DNA fragment shown in A with Pst I; 2, marker obtained by
cleaving the DNA of plasmid pBR322 with Hin F and then by end la-
beling; 3, DNA hybridized with yeast RNA (25 ,ag); 4, DNA hybridized
with yeast RNA and hydrolyzed with nuclease Si; 5, DNA hybridized
with virion RNA of RSV (unmeasured) and hydrolyzed with nuclease
Si; 6, DNA hybridized with 5 gg of total RNA from chicken cells in-
fected with RSV and hydrolyzed with nuclease Si; 7, DNA hybridized
with 50 ,ug of polyadenylylated RNA from uninfected chicken embryos
and hydrolyzed with nuclease S1. (C) The splice acceptor site. The se-
quences illustrated are located upstream of the initiation codons for v-
src and c-src. Nucleotides are numbered as in previous figures. The
smallest labeled DNA fragments generated in the splice-mapping pro-
cedure terminate at the positions marked with asterisks. Arrows in-
dicate the location of the splice site, which is inferred from the under-
lined consensus sequence (16).
We located the acceptor site in v-src and c-src mRNAs with
greater precision by fractionating the products of hydrolysis with
nuclease S1 in a gel designed for nucleotide sequence analysis
(data not shown). As markers, we used fragments of DNA gen-
erated by the procedure of Maxam and Gilbert (10) from the
same end-labeled DNA as was used for the splice mapping. The
results indicated that the splice acceptor site is located 75 nu-
cleotides upstream of the initiation codon for v-src, in the midst
of a suitable consensus sequence shared by v-src and c-src (Fig.
3C). We conclude that the domain of v-src extending from po-
sition -76 to position -91 (Fig. 3C) was derived from an intron
of c-src.
A Nucleotide Sequence with Variable Locations in the Ge-
nomes of RSV. Comparison of the genomes of SR-A and Pr-C
RSV upstream of the transduced domain of c-src revealed an
absence of homology (Fig. IC). Further inspection of nucleo-
tide sequences uncovered a sequence of 127 or 128 nucleotides
that is located to the left of v-src in SR-A RSV but to the right
of v-src in Pr-C RSV. The enigmatic nature of this sequence
prompted us to give it the arbitrary designation of X. Other
workers have also noted the presence of X in SR-A and Pr-C
RSV, but their definition of the boundaries of X is different
from ours (22).
The versions of X and their immediate environs as found in
the genomes of SR-A and Pr-C RSV are aligned in Fig. 4. Sev-
eral notable features are apparent. (i) The two versions ofX dis-
play more than 85% homology. (ii) It appears that a repetition
of 12 nucleotides may have at one time flanked X both in SR-
A and Pr-C RSV. The complete sequence (C-G-C-T-C-T-T-G-
C-A-T-A) is found at the leftward boundary of X in SR-A RSV
and at the rightward boundary ofX in Pr-C RSV. In SR-A RSV,
the rightward copy of the repeat lacks six nucleotides where X
abuts the transduced portion of c-src. By contrast, the leftward
copy of the repeat in Pr-C RSV lacks three nucleotides and is
interrupted by five nucleotides not found in the other versions
of the sequence. A single copy of the same sequence of 12 nu-
cleotides occurs in the genome of RAV-O, just upstream from
the U3 domain (Fig. 4). Since the genome of RAV-O does not
contain X, we presume that the 12-nucleotide sequence may
represent the site at which X was inserted (see Discussion).
We have used a molecular subelone containing a portion of
X to search for the sequence in the genomes of other avian ret-
roviruses. By molecular hybridization with cloned viral DNAs
immobilized on nitrocellulose, we found evidence for X in the
genomes of avian erythroblastosis virus and myelocytomatosis
virus but not in the genomes of RAV-0, RAV-1, RAV-2, and
PRC-II avian sarcoma virus (data not shown).
The Viral Boundaries of v-src. Having recognized and de-
fined X, we could now describe the topography surrounding v-
src in some detail. It appears likely that the same portion of c-
src has been transduced in both SR-A and Pr-C RSV (Fig. 5).
In both strains of virus, the transduced unit is flanked by a large
direct repeat recognized previously (12, 13, 23); the same se-
quence is present as a single copy in the genome of RAV-0. In
Pr-C, the repetition situated to the left of v-src includes a small
portion of the U3 domain (AU3) and the rightward version of
the repeat is interrupted by X. In SR-A, X intervenes between
the leftward version of the repeat and v-src, whereas the right-
ward copy of the repeat is undisturbed.
DISCUSSION
The Topographies of v-src and c-src. We have compared v-
src and c-src to explore the mechanism by which retroviruses
transduce cellular genes. Our analysis produced several find-
ings that bear on the relationship between the two genes. First,
less than the entire c-src gene has been transduced into RSV.
The domain between 10 and 75 nucleotides upstream of the
initiation codon in v-src represents an untranslated exon in c-
src. To the left of this exon, v-src contains a portion of an intron
from c-src that is joined to the presumed site of recombination
with a transducing virus. At least one additional untranslated
exon must lie upstream of this intron in c-src but it does not
appear in v-src. Second, the amino acid sequences at the car-
boxyl termini of v-src and c-src must differ from each other.
This observation extends previous indications that the proteins
encoded by the two genes may differ in subtle ways (24) and
may offer an explanation for the oncogenic potential of v-src.
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FIG. 4. X units of SR-A and Pr-C RSV. The sequences ofX have been aligned so as to achieve maximum homology. The boundaries assigned
to X are denoted by bold vertical bars, positions occupied by different nucleotides in two versions of X are marked by dots, and a sequence that
bracketsX to form direct repeats, and occurs but once in the genome of RAV-0, is underlined. Position -91 in the sequence of SR-ARSV represents
the beginning of v-src. The leftward boundary of U3 is marked for RAV-1 and Pr-C RSV.
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this inference is correct, X entered the retroviral genome prior
to src. The different locations ofX in SR-A and Pr-C RSV could
then be explained in at least two ways: either one copy of the
sequence has been deleted from each strain of virus or the se-
quence was present in only one of the two retroviruses partic-
ipating in the separate steps of transduction (see below and Fig.
6).
s generally begins at the AUG closest to Transduction of Cellular Genes by Retroviruses. The pre-
(25). vailing model for transduction of cellular genes by retroviruses
ice with Variable Locations in Genomes (18, 27-29) is outlined in Fig. 6. Fortuitous insertion of a retro-
tified a sequence of 127 or 128 nucleo- virus provirus upstream from a cellular oncogene is followed by
sat is found at different positions in the rearrangement of DNA that joins a leftward domain of the pro-
Pr-C RSV. The same or related se- virus and a portion of the cellular oncogene into a hybrid tran-
at least two other (but not all) avian ret- scriptional unit. Transcription of the unit and splicing produce
Af X and the means by which X reached chimeric RNA that is suitable for packaging into heterozygous
for the moment obscure. Our only clue retrovirus virions. Recombination during a subsequent infec-
'epeat of 12 nucleotides that flanks the tion generates a retrovirus genome that now includes the trans-
strains of RSV. The repeats apparently duced portion of the cellular oncogene.
By of the same sequence that resides in Several features of this model are evident from our com-
7oid of X and may therefore have arisen parison of v-src and c-src. (i) The leftward recombination with
a transposable genetic element (26). c-src apparently occurred within an intron, an event that can
he genome(s) of RSV, and why is it lo- be easily explained only if the initial step in transduction is a
ions in the SR-A and Pr-C strains? The rearrangement of DNA such as the deletion illustrated in Fig.
i the left boundary of v-src in SR-A RSV 6. (ii) v-src represents in part a spliced version of the homol-
ogous regions of c-src. (iii) The second recombination is pos-
tulated to occur between the spliced chimeric RNA and viral
env U3 RNA during the course of reverse transcription (Fig. 6). The
src recombination should therefore occur within an exon of c-src,
and homology between c-src and the transducing virus would
facilitate the crossing-over. We were not able to locate the
AU3 rightward point of recombination with c-src with any assur-
env M- U3 ance, but it appears to have taken place within an exon of c--<j src j tI.fr src-either a coding domain or an untranslated region of the
gene. Previous evidence indicates that recombination of the
sort conjectured can occur during the course of retroviral in-
fection (28). (iv) The large direct repeat that brackets v-src pre-
U5 gag pol env U3 sumably mirrors the occurrence of two separate recombinatory
e events, the first downstream of the progenitor for the repeated
sequence in transducing virus, the second upstream of the se-
avian retrovirus genomes. (A) SR-A. (B) Pr- quence (see asterisks in Fig. 6).
Leavy arrows, the sequence of 120 nucleo- Our present conclusions are in accord with recent findings
acket src in RSV but occurs only once in RAV- forOurbpre conlusions ar in acor withrecentfn gified sequence X; sinusoidal lines, the 5' non- oc-myb- the cellular gene that gave rise to the oncogene (v-Lnsduced into RSV; broken line, the 3' non- myb) of avian myeloblastosis virus (30). (i) The leftward recoi-
origin; AU3, a portion of the U3 domain in bination with c-myb occurred within an intron (ref. 30; un-
published data). (ii) Multiple introns within the transduced por-
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FIG. 6. Model for the transduction of cellular oncogenes by retro-
viruses.
tion of c-myb are precisely spliced out of v-myb (30). (iii) The
rightward recombination with c-myb occurred within an exon
of c-myb and without benefit of extensive homology between
c-myb and the genome of the transducing virus.
Were the SR and Pr strains of RSV formed by independent
transductions of c-src, or were both derived from a single trans-
duction? Although the two strains of virus were isolated sep-
arately (31), it is possible that they are merely divergent rep-
resentations of the same transduction. The data presented above
provide circumstantial evidence both for and against this pos-
sibility. We see no way to reach a decisive conclusion unless
new and more telling information can be obtained.
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